About Innovel Intelligent Technology
Innovel Intelligent Technology is a Healthcare company based in Suzhou (China) founded in 2018. Bioreactors and automated systems for cell culture production are supplied. Innovel Intelligent Technology has raised $15.28 million across 1 funding round. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors.
Company details
Provider of bioreactors for cell culture. The company has developed an automatic system ImmunoBase and InnoFluid for the production of biological drugs and industrial-scale production, testing, and storage. IMMUNOBASE is new series of bioreactors without agitating paddles for laboratories and large-scale production and InnoFluid is a research-grade liquid circulating perfusion reactor for the production of antibodies, viruses, and cells. The company has also developed ImmunoVessel made of breathable membrane technology that optimizes the breathability of the culture bottle, ImmunoDuct to enhance virus transduction efficiency, and InnoIncubator is a fully automatic high-efficiency incubator for large-scale cultivation of cell products.
- Headquarters Suzhou, China
- SectorsHealthcare
- Website sinoinnovel.com/en
- Social YouTube
- Total Equity Funding$15.28M (USD)
in 1 rounds
- Latest Funding Round$15.28M (USD), Series A
Mar 2021
Apps and channels of Innovel Intelligent Technology
its YouTube channel INNOVEL has 21 subscribers and 8 videos.
Videos from Innovel Intelligent Technology
The most watched videos on Innovel Intelligent Technology's YouTube channel, INNOVEL (21 subscribers). Click a video to play it here.
More on INNOVEL.
Funding Insights of Innovel Intelligent Technology
Innovel Intelligent Technology has successfully raised a total of $15.28M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.28 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.28M
- Total Rounds 1
- Last Round Series A — $15.28M
- First Round $15.28M
(Mar 2021)
All 1 funding rounds of Innovel Intelligent Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $15.28M | Series A | – | – | – |
Timeline of Innovel Intelligent Technology
2 dated milestones of Innovel Intelligent Technology across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Innovel Intelligent Technology is founded.
- Funding First funding round of $15.3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Innovel Intelligent Technology
Innovel Intelligent Technology was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Innovel Intelligent Technology is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Innovel Intelligent Technology is a funded company, having raised a total of $15.28M across 1 funding round to date. The company's 1st funding round was a Series A of $15.28M, raised on Mar 2021.
Provider of bioreactors for cell culture. The company has developed an automatic system ImmunoBase and InnoFluid for the production of biological drugs and industrial-scale production, testing, and storage. IMMUNOBASE is new series of bioreactors without agitating paddles for laboratories and large-scale production and InnoFluid is a research-grade liquid circulating perfusion reactor for the production of antibodies, viruses, and cells. The company has also developed ImmunoVessel made of breathable membrane technology that optimizes the breathability of the culture bottle, ImmunoDuct to enhance virus transduction efficiency, and InnoIncubator is a fully automatic high-efficiency incubator for large-scale cultivation of cell products.